Puma Biotechnology
PBYI
PBYI
92 hedge funds and large institutions have $1.21B invested in Puma Biotechnology in 2013 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 35 increasing their positions, 32 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.07% more ownership
Funds ownership: 79.12% → 79.19% (+0.07%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
92
Holding in Top 10
1
Calls
$307K
Puts
–
Top Buyers
| 1 | +$78.4M | |
| 2 | +$17.1M | |
| 3 | +$10.2M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$8.68M |
| 5 |
SCM
Sigma Capital Management
Stamford,
Connecticut
|
+$5.63M |
Top Sellers
| 1 | -$22.1M | |
| 2 | -$14.6M | |
| 3 | -$14.2M | |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$13.6M |
| 5 |
O
OrbiMed
New York
|
-$13.1M |